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ABSTRACT
Rhodococcus equi is a facultative aerobic, intracellular, non-motile, non-spore-forming, 
Gram-positive, weakly acid-fast coccobacillus belonging to the group of nocardioform 
actinomycetes. R. equi infections are rare opportunistic illnesses in patients with Acquired 
Immunodeficiency Syndrome (AIDS), associated with a high mortality rate. The most 
common clinical presentation of R. equi infections is a chronic cavitary pneumonia. Due to 
its acid-fastness, R. equi can be mistaken for others acid-fast organisms, as Mycobacterium 
tuberculosis. In turn, R. equi is also a gram-positive pleomorphic bacteria and can be 
mistaken for diphtheroids or Micrococcus organisms, being accidentally disregarded as oral 
contaminants in sputum cultures. Therefore, in Brazil, a highly prevalent tuberculosis (TB) 
country, pulmonary infections caused by R. equi may mimic pulmonary TB and represent a 
diagnostic challenge. Here, we report on a case of chronic cavitary pneumonia by R. equi in 
a Human Immunodeficiency Virus (HIV)-infected patient, focusing on diagnostic aspects.
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INTRODUCTION
Rhodococcus equi is a facultative aerobic, intracellular, non-motile, non-spore-
forming, Gram-positive, weakly acid-fast coccobacillus belonging to the group of 
nocardioform actinomycetes1. R. equi is a pathogen of well-recognized relevance 
in veterinary medicine, causing lung abscess in foals and submaxillary adenitis 
in swine2. Since the first report of human infection in 19673, R. equi has been 
appreciated as an opportunistic pathogen, especially in patients with impaired 
immune system such as organ solid and hematopoietic stem cells recipients and 
HIV-infected patients4. 
Due to AIDS epidemic, the human infections by R. equi are increasing in 
frequency1,4. Most of R. equi infections occur in HIV-infected patients with a CD4 T 
lymphocytes count below 200 cells/μL and the most common clinical presentation 
is a chronic cavitary pneumonia, similar to foals2,5. Extrapulmonary disease, with 
or without concomitant pulmonary infection, can also occur and affects mainly 
central nervous system as well as skin and soft tissues5. The R. equi disease has a 
high mortality rate in AIDS patients. Besides a prolonged combination antibiotic 
therapy, antiretroviral therapy (ART) is also important and associated with higher 
survival rates in HIV-infected patients5,6.
Here, we report on a case of a chronic cavitary pneumonia by Rhodococcus equi 
in a HIV-infected patient, focusing on diagnostic aspects. 
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CASE REPORT
A 45-year-old HIV-infected man, a hairdresser, sought 
our emergency department on May 2017 complaining of 
productive cough for 7 months, with a purulent sputum, 
associated with a pleuritic chest pain on the right side. 
During this time, the patient reported high intensity fever 
(axillary temperature of 39 ºC) accompanied by anorexia, 
asthenia and weight loss of 5 kg. Over the last month, he 
also referred progressive dyspnea on exertion. The patient 
denied other symptoms.
The HIV infection has been diagnosed 4 years ago 
and his current ART consisted of efavirenz, zidovudine 
and lamivudine. His medical history was remarkable for 
the poor adherence to ART in the last 2 years. Recent 
CD4 and CD8 T lymphocytes counts were 45 (5.0%) 
and 517 (57.0%) cells/μL respectively, and the viral load 
was 199,233 copies/mL (5.299 Log10). He had previous 
hospitalizations for cerebral toxoplasmosis on 2013, 
his AIDS-defining opportunistic illness, and retinal 
detachment secondary to cytomegalovirus retinitis on 
July 2016. His mother had pulmonary tuberculosis 
30 years ago. The patient used to drink fermented 
beverages occasionally and smoke almost a cigarette pack 
daily. He lived in the outskirts of Natal, the capital of Rio 
Grande do Norte State, Brazil, and raised a cat, a dog, 
chickens and a horse in the backyard. 
On admission, vital signs were axillary temperature 
38.4 ºC, blood pressure 100/60 mmHg, pulse rate 99 bpm 
and respiratory rate 25/min. The physical examination was 
remarkable for the presence of oropharyngeal candidiasis 
and diminished vesicular breath sounds with inspiratory 
crackles heard in the area of right mid and lower lung 
fields. Laboratory tests initially showed: hemoglobin of 
10.8 g/L, white cells count of 5.7 x 109/L (76% neutrophils 
and 18% lymphocytes) and platelet counts of 134 x 109/L. 
The kidney and liver function tests were normal. The 
serum lactate dehydrogenase level was also normal. Chest 
X-ray showed an area of consolidation with a thick walled 
cavitation containing an air-fluid level on the right mid 
lung field (Figure 1A). Computed tomography of the 
chest showed a pleuropulmonary fluid-gas collection with 
thickened walls and irregular edges, located in the anterior 
portion of the middle third of the right hemithorax, with an 
estimated volume of 288 mL (Figure 1B). Blood cultures 
were negative for bacteria and fungi. 
The patient’s sputum samples were collected. An 
acid-fast bacilli smear of the specimen was negative on 
Ziehl-Neelsen stain, but showed coccobacillary organisms 
on modified Kinyoun stain (Figure 2A). The GeneXpert 
MTB/RIF sputum test was negative. Then, the specimen 
was inoculated on 5% sheep blood agar, chocolate agar 
and MacConkey’s agar plates incubated for 48 h at 
37 ºC. The sputum sample was also treated by N-acetyl 
Figure 1 - A) Chest X-ray showing a consolidation area with a thick -walled cavitation containing an air-fluid level in the right mid 
lung field on the patient’s admission; B) Computed tomography showing a pleuropulmonary fluid-gas collection located in the right 
middle lung lobe; C) Chest X-ray showing linear fibrotic bands with cicatricial appearance in the right mid lung field four months 
after treatment for Rhodococcus equi pneumonia.
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L-cysteine sodium hydroxide method, inoculated on slopes 
of Lowenstein-Jensen medium and incubated for 8 weeks 
at 37 ºC in 5-10% CO2. Pink colored and smooth mucoid 
bacteria colonies grown on sheep blood and chocolate 
agar (Figure 2B), but not on MacConkey’s agar. The 
direct microscopic examination on Gram stain showed 
Gram-positive coccobacilli (Figure 2C) and acid-fast on 
Kinyoun stain. The mycobacterial culture was negative. 
The isolate was identified by Vitek® 2 automated system 
(software version 7.01) as Kocuria rosea (95% probability) 
using Vitek 2 GP ID card. However, Kocuria rosea is not 
an acid-fast organism and it is not implicated in pulmonary 
infections. Considering the possibility of misidentification 
of the isolate by Vitek® 2, the strain was sent to the 
Microbiology Laboratory of Hospital das Clínicas, São 
Paulo, Brazil for identification by using matrix-assisted laser 
desorption ionization-time of flight (MALDI-TOF) Vitek® 
mass spectrometry (MS). It identified the patient’s isolate as 
Rhodococcus equi with 93% probability (Figure 2D). 
The patient was treated for chronic necrotizing 
pneumonia by Rhodococcus equi with amikacin at a 
dose of 1g/day intravenously (IV), imipenem at 500 mg 
q6h IV and moxifloxacin 400 mg daily IV for 2 months at 
inpatient treatment. After that, he took orally an outpatient 
combination therapy with levofloxacin at 500 mg daily, 
trimethoprim-sulfamethoxazole 160/800 mg q12h and 
azithromycin 500 mg daily for 4 months. The patient 
had an excellent response to treatment and the symptoms 
disappeared completely. Chest X-ray performed four 
months after treatment showed fibrotic changes in middle 
zone of the right lung (Figure 1C). The antiretroviral therapy 
has switched for dolutegravir at 50 mg daily combined 
with ritonavir-boosted darunavir at 600 mg q12h after 
genotypic resistance assay results. The CD4 lymphocyte 
count increased to 236 cells/μL and HIV viral load was 
undetectable. The patient did not develop the immune 
reconstitution inflammatory syndrome nor the relapse of 
the disease. After treatment, he kept using a trimethoprim-
sulfamethoxazole double-strength tablet for prophylaxis of 
R. equi infection and Pneumocystis jirovecii pneumonia.
DISCUSSION
AIDS is the major predisposing immunosuppressive 
condition for R. equi infections accounting for about 
two-thirds of cases7. In HIV-infected patients, pulmonary 
Figure 2 - A) Acid-fast coccobacillary organisms in modified Kinyoun stain; B) Smooth mucoid pink bacteria colonies yielded on 
5% sheep blood agar plate; C) Gram-positive coccobacillus with diphtheroid-like morphology in Gram stain; D) Rhodococcus equi 
spectral signature from Vitek® MS with Saramis® Software.
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infections are also the most common clinical presentation 
of R. equi infections, observed in more than 80% of cases, 
and present usually as a subacute or chronic necrotizing 
pneumonia5,8. Compared with non-HIV-infected individuals, 
the symptoms of R. equi pneumonia are similar in AIDS 
patients, but more cases of extrapulmonary disease, with or 
without concurrent pneumonia are found in the latter group7,9.
The soil and gut of herbivorous animals are the natural 
reservoirs of R. equi and the bacterium meets optimal 
conditions for growth in horse manure2,7,9. The high 
frequency of pulmonary infections in immunocompromised 
humans indicates that the main mode of R. equi acquisition 
is the inhalation of contaminated material from the soil7,8. 
Takai et al.10 reported that the number of R. equi isolated 
from the air on horse farms increased on warmer, dry and 
windy days, suggesting aerosolization of soil particles 
contaminated with R. equi as a transmission mechanism. 
In HIV- and non-HIV-infected patients with pulmonary 
disease by R. equi, areas of consolidation with cavitation are 
the most common radiological features5,6,9,11,12. Cavitation 
is found in more than 75% of cases and lung abnormalities 
are predominantly located in the upper lobes (55%)11,12. 
Similar to other HIV-infected patients, our patient had 
Rhodococcus equi pneumonia with cavitation, even though 
he was severely immunosuppressed, suggesting a direct 
action of the bacterium causing lung lesions, and not by 
the host's immune response. 
In fact, the pathogenic potential of R. equi is associated 
with its ability to survive inside macrophages and destroy 
them2. The bacterium evades intracellular killing by 
interfering with the phagosome-lysosome fusion, by 
the cell wall mycolic acids and by a surface lipoprotein 
named Virulence-associated protein (Vap). These factors 
play a relevant role in this survival mechanism2,7,13. In 
addition, R. equi induces a non-specific degranulation of 
infected macrophages, contributing to tissue destruction 
and neutrophil influx2. 
In this case, the patient has raised a horse in backyard. 
This was probably the epidemiological clue for the diagnosis 
of R. equi pneumonia. However, a history of contact with farm 
animals, herbivorous manure or occupational exposure is not 
always present on reports6,8,9. One explanation is that this type 
of information is not actively sought in clinical practice and 
most of studies about R. equi infections are retrospective. 
When R. equi infection is suspected, the medical 
staff should explicitly inform this possibility to clinical 
microbiologists for the following reasons. Firstly, R. equi 
is a pleomorphic bacterium whose morphology varies 
from coccoid to bacillary depending on the specimen 
type, growth conditions and type of medium, and it may 
be mistaken for oral cavity contaminants as diphtheroid 
or Micrococcus organisms1,2,7. Therefore, in pulmonary 
infections, R. equi might be present in sputum culture 
mixed with other pathogens, or even in pure culture, and 
be disregarded due to the diphtheroid aspect. 
Secondly, it is important to choose a reliable 
identification method for R. equi. Conventional methods, 
based on laboratory bench biochemical tests, can be lengthy 
and laborious to be performed in a clinical laboratory 
routine2,14. In turn, automated methods would come to solve 
these negative points. Nevertheless, misidentification by 
automated systems could occur with a potential negative 
impact on diagnosis and treatment of the patient, as we 
observed in this case.
The automated system Vitek® 2 misidentified R. equi 
isolate as Kocuria rosea with 95% probability (very good). In 
fact, Vitek® 2 identification cards are not capable to identify 
correctly R. equi isolates15 and this is a method limitation. 
Interestingly, K. rosea is a member of the Micrococcaceae 
family, which also includes Micrococcus species16, with 
which R. equi has already been mistaken7. K. rosea is part of 
the oral cavity microbiota and is not implicated in pulmonary 
infections, even in immunosuppressed patients16. In addition, 
K. rosea is not an acid-fast organism and this was the clue to 
the problem of misidentification. 
MALDI-TOF mass spectrometry has proved to be a 
reliable method for identification of R. equi isolates with a 
rapid turn-around time17. We believe MALDI-TOF might be 
advantageous in the context of R. equi infections due to its 
ability to diagnose early and accurately, allowing immediate 
treatment of an infection with high mortality rates in 
immunosuppressed patients, especially in HIV-infected 
individuals5,6,8,9. 
The third reason is that R. equi is an acid-fast organism 
due to presence of mycolic acids in its cell wall. That is 
why R. equi may be mistaken for other acid-fast pathogens, 
especially Mycobacterium tuberculosis2,4,7. Nevertheless, 
unlike M. tuberculosis, R. equi is weakly acid-fast and non-
alcohol fast18. In this case, acid-fast testing was negative 
in Ziehl-Neelsen stain and positive in modified Kinyoun 
stain. This illustrates the importance of using other modified 
acid-fast techniques in suspected R. equi infections cases, as 
Kinyoun staining, to reveal R. equi acid-fastness, because 
Kinyoun stain is based on an aqueous solution of a weak 
acid, 1% sulfuric acid, to promote the discoloration1,18. 
Our patient lives in Brazil, a country with a high 
burden of tuberculosis (TB) where current data estimate 
an incidence of 42 cases per 100,000 inhabitants, and a 
HIV infection prevalence in incident TB cases of 13%19. 
Classically, pulmonary TB presents as chronic cavitary 
disease. It is also known that a positive acid-fast sputum 
smear often leads to anti-tuberculosis treatment initiation 
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in limited resources settings19. However, this is the 
typical presentation in immunocompetent individuals. In 
HIV-infected patients with CD4 lymphocyte counts below 
200 cels/μL, pulmonary TB usually has no cavitation and 
a lower frequency of positive sputum smears20. 
Therefore, on clinical and radiographic grounds, R. equi 
pulmonary infections can mimicry pulmonary tuberculosis, 
but should be considered more likely as the cause of 
cavitary pneumonia in HIV-infected patients with severe 
immunosuppression than M. tuberculosis mostly when: 
1) there is a negative acid-fast sputum smear and only Ziehl-
Neelsen staining was used; 2) a modified acid-fast staining 
shows the presence of acid-fast cocobacillary bacteria; 3) 
history of contact with farm animals or herbivorous manure 
or occupational exposure is present. 
CONCLUSION
R. equi infection is a rare opportunistic illness in patients 
with AIDS and usually presents as pulmonary infections. 
R. equi should be included in the differential diagnosis of 
chronic cavitary pneumonia in HIV-infected patients with 
severe immunosuppression, especially in the presence of 
epidemiological history of contact with farm animals or 
herbivorous manure. In limited resources settings, when 
a gram-positive coccobacillus is observed in sputum 
smears and it is positive in an acid-fast staining, we are 
presumptively facing a R. equi isolate, taking into account 
the characteristic clinical-epidemiological context. 
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